"Cancer center in Coeur d'Alene, ID providing medical oncology and hematology services."

During the past decade, Beacon Cancer Care conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Cancer Care" #1 sponsor was "CytomX Therapeutics" with 1 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Mirati Therapeutics Inc." with 1 trials sponsored and "Oncopeptides AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Cancer Care" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Cancer Care" are "Locally Advanced or Metastatic Urothelial Carcinoma" (1 trials), "Metastatic Non-Squamous Non-Small Cell Lung Cancer" (1 trials), "Relapsed and/or Refractory Multiple Myeloma" (1 trials), "Soft Tissue Sarcoma" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Beacon Cancer Care" in a lesser frequency.

Most popular intervention types in "Beacon Cancer Care" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "CX-072" (1 trials), "Dexamethasone" (1 trials), "Docetaxel" (1 trials) and "Ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Cancer Care" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Beacon Cancer Care". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Beacon Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Cancer Care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".